11:51 AM EST - Concordia International Corp. : Announced that the U.S. Food and Drug Administration has approved the Company's premarket approval application (PMA) for its new Photofrin® 630 PDT Laser. Concordia International Corp.
shares T.CXR are trading up $0.84 at $27.55.
